Company / Depreciation & Amortization
Niagen Bioscience, Inc. Depreciation & Amortization History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$870.0K
FY2024
5-year range
$869.0K / $890.0K
FY2020-FY2024
Trend
+0.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $890,000 to $870,000 over the past 2 years.
Based on SEC 10-K filings.
$870,000 in FY2024 with a 3-year CAGR of -0.0%.
Improved from $890,000 to $870,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -0.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -0.0%, indicating a declining trend.
- In FY2024, depreciation & amortization increased 0.1% year-over-year.
- Peak depreciation & amortization was recorded in FY2022.
- Lowest depreciation & amortization in the period was in FY2016.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $870.0K | +0.1% |
| FY2023 | $869.0K | -2.4% |
| FY2022 | $890.0K | +2.2% |
| FY2021 | $871.0K | +14.3% |
| FY2020 | $762.0K | - |
| FY2019 | - | - |
| FY2018 | $510.0K | +0.0% |
| FY2017 | $510.0K | +53.6% |
| FY2016 | $332.0K | +16.1% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026